1285539-70-9

Basic information

• Product Name: 5-amino-2-ethoxy-N-(3-methoxyphenyl)-benzamide
• Synonyms: 5-amino-2-ethoxy-N-(3-methoxyphenyl)-benzamide
• CAS NO: 1285539-70-9
• Molecular Weight: 286.331
• Mol File: 1285539-70-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 5-amino-2-ethoxy-N-(3-methoxyphenyl)-benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 5-amino-2-ethoxy-N-(3-methoxyphenyl)-benzamide(1285539-70-9)
• EPA Substance Registry System: 5-amino-2-ethoxy-N-(3-methoxyphenyl)-benzamide(1285539-70-9)

Safety Data

• Hazardous Substances Data: 1285539-70-9(Hazardous Substances Data)

Upstream product

• 90537-40-9 2-ethoxy-5-nitrobenzoyl chloride 
• 591-27-5 m-Hydroxyaniline 
• 57148-23-9 2-ethoxy-5-nitro-benzoic acid 
• 17302-46-4 methyl 2-hydroxy-5-nitrobenzoate 
• 96-97-9 5-nitrosalicylic acid 
• 80074-34-6 2-ethoxy-5-nitro-benzoic acid methyl ester 
• 1285539-31-2 2-ethoxy-N-(3-methoxyphenyl)-5-nitrobenzamide 
• 1285539-49-2 2-ethoxy-N-(3-hydroxyphenyl)-5-nitrobenzamide 
• 536-90-3 m-Anisidine 

Relevant articles and documents

Discovery of novel high potent and cellular active ADC type PTP1B inhibitors with selectivity over TC-PTP via modification interacting with C site

PTP1B serving as a key negative regulator of insulin signaling is a novel target for type 2 diabetes and obesity. Modification at ring B of N-{4-[(3-Phenyl-ureido)-methyl]-phenyl}-methane-sulfonamide template to interact with residues Arg47 and Lys41 in t

5-[3-(2,5-diethoxy-4-methylsulfonyl-benzyl)-ureido]-2-ethoxy-N-(3-methoxy-phenyl)-benzamide new compound and preparation method and application thereof

The invention provides a new compound. The name of the compound is 5-[3-(2,5-diethoxy-4-methylsulfonyl-benzyl)-ureido]-2-ethoxy-N-(3-methoxy-phenyl)-benzamide; molecular weight of the compound is 600.6; and structure of the compound is as shown in the structural formula (compound 1). Meanwhile, the invention provides a preparation method of the compound 1. The compound provided by the invention has good drug-likeness and can be used in the research field of new drugs, especially in the research field of type-II diabetes innovative drugs.